BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 23219537)

  • 21. Prospective comprehensive assessment of sexual function after retropubic non nerve sparing radical prostatectomy for localized prostate cancer.
    Trinchieri A; Nicola M; Masini F; Mangiarotti B
    Arch Ital Urol Androl; 2005 Dec; 77(4):219-23. PubMed ID: 16444937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of phosphodiesterase type 5 (PDE5) inhibitors in treating erectile dysfunction after bilateral nerve-sparing radical prostatectomy.
    Cui Y; Liu X; Shi L; Gao Z
    Andrologia; 2016 Feb; 48(1):20-8. PubMed ID: 25684196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy.
    Cavallini G; Modenini F; Vitali G; Koverech A
    Urology; 2005 Nov; 66(5):1080-5. PubMed ID: 16286128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5mg and 10mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial.
    Porst H; Giuliano F; Glina S; Ralph D; Casabé AR; Elion-Mboussa A; Shen W; Whitaker JS
    Eur Urol; 2006 Aug; 50(2):351-9. PubMed ID: 16766116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Avanafil for the treatment of erectile dysfunction. An updated review.
    Egui-Rojo MA; Moncada-Iribarren I; Carballido-Rodríguez J; Martínez-Salamanca JI
    Arch Esp Urol; 2014 Dec; 67(10):839-47. PubMed ID: 25582903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preserved postoperative penile size correlates well with maintained erectile function after bilateral nerve-sparing radical retropubic prostatectomy.
    Briganti A; Fabbri F; Salonia A; Gallina A; Chun FK; Dehò F; Zanni G; Suardi N; Karakiewicz PI; Rigatti P; Montorsi F
    Eur Urol; 2007 Sep; 52(3):702-7. PubMed ID: 17418936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of tadalafil in men with erectile dysfunction following spinal cord injury.
    Giuliano F; Sanchez-Ramos A; Löchner-Ernst D; Del Popolo G; Cruz N; Leriche A; Lombardi G; Reichert S; Dahl P; Elion-Mboussa A; Casariego J
    Arch Neurol; 2007 Nov; 64(11):1584-92. PubMed ID: 17846260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and efficacy of sildenafil citrate in the treatment of Parkinson-emergent erectile dysfunction: a double-blind, placebo-controlled, randomized study.
    Safarinejad MR; Taghva A; Shekarchi B; Safarinejad Sh
    Int J Impot Res; 2010; 22(5):325-35. PubMed ID: 20861846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of erectile function after laparoscopic radical prostatectomy in a single center.
    Cathala N; Mombet A; Sanchez-Salas R; Rozet F; Barret E; Giuliano F; Galiano M; Prapotnich D; Kazzazi A; Djavan B; Jaffe J; Cathelineau X; Vallancien G
    Can J Urol; 2012 Aug; 19(4):6328-35. PubMed ID: 22892254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of once-daily tadalafil in men with erectile dysfunction who reported no successful intercourse attempts at baseline.
    Shabsigh R; Seftel AD; Kim ED; Ni X; Burns PR
    J Sex Med; 2013 Mar; 10(3):844-56. PubMed ID: 23035781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The efficacy and safety of tadalafil in United States and Puerto Rican men with erectile dysfunction.
    Seftel AD; Wilson SK; Knapp PM; Shin J; Wang WC; Ahuja S
    J Urol; 2004 Aug; 172(2):652-7. PubMed ID: 15247754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy and safety of udenafil, a new selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction.
    Paick JS; Kim SW; Yang DY; Kim JJ; Lee SW; Ahn TY; Choi HK; Suh JK; Kim SC
    J Sex Med; 2008 Apr; 5(4):946-953. PubMed ID: 18221288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acceptance of and discontinuation rate from erectile dysfunction oral treatment in patients following bilateral nerve-sparing radical prostatectomy.
    Salonia A; Gallina A; Zanni G; Briganti A; Dehò F; Saccà A; Suardi N; Barbieri L; Guazzoni G; Rigatti P; Montorsi F
    Eur Urol; 2008 Mar; 53(3):564-70. PubMed ID: 17761385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Avanafil: a review of its use in patients with erectile dysfunction.
    Sanford M
    Drugs Aging; 2013 Oct; 30(10):853-62. PubMed ID: 23955441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sildenafil citrate after radical retropubic prostatectomy.
    Lowentritt BH; Scardino PT; Miles BJ; Orejuela FJ; Schatte EC; Slawin KM; Elliott SP; Kim ED
    J Urol; 1999 Nov; 162(5):1614-7. PubMed ID: 10524880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of on-demand tadalafil for the treatment of erectile dysfunction in South-East Asian men.
    Guo YL; Zhu JC; Pan TM; Ding Q; Wang YX; Cheong NF; Lim E; Shen W; Venugopalan M; Chan M
    Int J Urol; 2006 Jun; 13(6):721-7. PubMed ID: 16834650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of once-daily dosing of udenafil in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial.
    Zhao C; Kim SW; Yang DY; Kim JJ; Park NC; Lee SW; Paick JS; Ahn TY; Min KS; Park K; Park JK
    Eur Urol; 2011 Aug; 60(2):380-7. PubMed ID: 21458153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effectiveness and safety of avanafil for erectile dysfunction: a systematic review and meta-analysis.
    Wang H; Yuan J; Hu X; Tao K; Liu J; Hu D
    Curr Med Res Opin; 2014 Aug; 30(8):1565-71. PubMed ID: 24701971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of avanafil 200 mg versus sildenafil 100 mg in the treatment of erectile dysfunction after robot-assisted unilateral nerve-sparing prostatectomy: A prospective multicentre study.
    Della Camera PA; Tellini R; Cito G; Rastrelli G; Maggi M; Chini T; Nunzio C; Altieri VM; Serni S; Gacci M; Natali A
    Urologia; 2020 Feb; 87(1):23-28. PubMed ID: 31441379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study.
    Roehrborn CG; McVary KT; Elion-Mboussa A; Viktrup L
    J Urol; 2008 Oct; 180(4):1228-34. PubMed ID: 18722631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.